Ebola-Vaccine

Will a global supply of Ebola vaccine be beneficial?

The vaccine alliance Gavi orders 500 doses of Ebola vaccine in order to have a stock to deal with a new wave of the disease.

More than 300 000 people in the Democratic Republic of Congo and in the neighboring countries received a dose of the Ebola vaccine, Ervebo, developped by the Merck Laboratory. As a reminder, this vaccine is pre-qualify by the World Health Organization in November 2019 and is immediately approved by the main Health Agencies.

Read more: Covid-19 kills two Malawian ministers on the same day

This vaccine proved its worth when the epidemic raged in the province of North-Kivu and Ituri until last June.

Read more: Tanzania prefers to use local herbs rather than using any vaccine against Covid-19

Leave a Reply

Your email address will not be published.